Swiss National Bank
VERA icon

Swiss National Bank’s Vera Therapeutics VERA Stock Holding History

Swiss National Bank’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69M Buy
85,900
+10,300
+14% +$384K ﹤0.01% 1611
2026
Q1 		$3.04M Hold
75,600
– – ﹤0.01% 1630
2025
Q4 		$3.83M Sell
75,600
-4,800
-6% -$170K ﹤0.01% 1502
2025
Q3 		$2.34M Sell
80,400
-5,000
-6% -$116K ﹤0.01% 1776
2025
Q2 		$2.01M Hold
85,400
– – ﹤0.01% 1809
2025
Q1 		$2.05M Hold
85,400
– – ﹤0.01% 1748
2024
Q4 		$3.61M Buy
85,400
+15,700
+23% +$695K ﹤0.01% 1513
2024
Q3 		$3.08M Hold
69,700
– – ﹤0.01% 1612
2024
Q2 		$2.52M Buy
69,700
+7,500
+12% +$297K ﹤0.01% 1691
2024
Q1 		$2.68M Buy
62,200
+13,500
+28% +$481K ﹤0.01% 1679
2023
Q4 		$749K Hold
48,700
– – ﹤0.01% 2382
2023
Q3 		$668K Buy
+48,700
New +$836K ﹤0.01% 2429
2023
Q1 		– Sell
-35,900
Closed -$695K – 2670
2022
Q4 		$695K Buy
35,900
+1,200
+3% +$21.7K ﹤0.01% 2492
2022
Q3 		$739K Hold
34,700
– – ﹤0.01% 2452
2022
Q2 		$472K Buy
+34,700
New +$606K ﹤0.01% 2619

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Swiss National Bank's VERA Position: Q2 2026 in Review

Swiss National Bank increased its Vera Therapeutics (VERA) stake by 14% in Q2 2026, buying an estimated $384K and bringing the position to 85,900 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1611.

Swiss National Bank first reported a position in VERA in Q2 2022 and has held it in 15 quarters since. The position peaked at $3.83M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Swiss National Bank held 85,900 shares of Vera Therapeutics worth $3.69M as of Q2 2026.
  • Swiss National Bank bought 10,300 Vera Therapeutics shares in Q2 2026, an estimated $384K.
  • Vera Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1611 holding.
  • Swiss National Bank first reported a position in Vera Therapeutics in Q2 2022 and has held it in 15 quarters since.
  • Swiss National Bank's Vera Therapeutics position peaked at $3.83M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.